Carlos Castañeda Altamirano

15PUBLICATIONS
105CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersSolid tumoursMidwifery not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 23, 2026
Breast cancer protective genetic variant common in women of Indigenous American genetic ancestry is a cis-eQTL for RMND1, ARMT1, and CCDC170 in HER2-enriched tumor subtypes.

|Aug 31, 2026
Midkine and CA9 Are Potential Cancer Stem Cell Biomarkers in Triple-Negative Breast Tumours.

|Jan 12, 2026
Giant Primary Hepatic Endodermal Sinus Tumor: Multidisciplinary Management and Long-Term Survival.

Katia Roque, Rossana Ruiz, Renier Cruz

|Nov 24, 2025
Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple-Negative Breast Cancer.

Zaida Morante, Yomali Ferreyra, Iris Otoya

|Dec 03, 2024
Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage.

Xiaosong Huang, Paul C Lott, Donglei Hu

|Jul 04, 2024
Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2-Positive Breast Cancer.

Iris Otoya, Natalia Valdiviezo, Zaida Morante

Pageof 3

Frequent Collaborators

9 joint publications

Miluska Castillo

7 joint publications

Luis Bernabe

6 joint publications

Julio E Abugattas

6 joint publications

Joselyn Sanchez